XML 54 R43.htm IDEA: XBRL DOCUMENT v3.20.2
Revenue - Business Revenue (Details) - USD ($)
3 Months Ended 9 Months Ended
Jun. 27, 2020
Jun. 29, 2019
Jun. 27, 2020
Jun. 29, 2019
Disaggregation of Revenue [Line Items]        
Revenues $ 822,900,000 $ 852,400,000 $ 2,429,500,000 $ 2,501,400,000
Contract with Customer, Liability, Revenue Recognized 18,000,000.0   95,500,000  
United States        
Disaggregation of Revenue [Line Items]        
Revenues 660,800,000 642,500,000 1,868,500,000 1,879,700,000
International        
Disaggregation of Revenue [Line Items]        
Revenues 162,100,000 209,900,000 561,000,000.0 621,700,000
Diagnostics        
Disaggregation of Revenue [Line Items]        
Revenues 532,200,000 305,400,000 1,163,200,000 898,600,000
Diagnostics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 439,100,000 231,200,000 909,100,000 685,500,000
Diagnostics | International        
Disaggregation of Revenue [Line Items]        
Revenues 93,100,000 74,200,000 254,100,000 213,100,000
Diagnostics | Cytology & Perinatal        
Disaggregation of Revenue [Line Items]        
Revenues 64,100,000 120,300,000 298,700,000 353,900,000
Diagnostics | Cytology & Perinatal | United States        
Disaggregation of Revenue [Line Items]        
Revenues 40,300,000 78,500,000 191,100,000 234,300,000
Diagnostics | Cytology & Perinatal | International        
Disaggregation of Revenue [Line Items]        
Revenues 23,800,000 41,800,000 107,600,000 119,600,000
Diagnostics | Molecular Diagnostics        
Disaggregation of Revenue [Line Items]        
Revenues 460,300,000 170,900,000 829,500,000 502,900,000
Diagnostics | Molecular Diagnostics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 391,000,000.0 138,500,000 683,000,000.0 409,400,000
Diagnostics | Molecular Diagnostics | International        
Disaggregation of Revenue [Line Items]        
Revenues 69,300,000 32,400,000 146,500,000 93,500,000
Diagnostics | Blood Screening        
Disaggregation of Revenue [Line Items]        
Revenues 7,800,000 14,200,000 35,000,000.0 41,800,000
Diagnostics | Blood Screening | United States        
Disaggregation of Revenue [Line Items]        
Revenues 7,800,000 14,200,000 35,000,000.0 41,800,000
Diagnostics | Blood Screening | International        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Breast Health        
Disaggregation of Revenue [Line Items]        
Revenues 224,000,000.0 325,400,000 862,800,000 971,600,000
Breast Health | United States        
Disaggregation of Revenue [Line Items]        
Revenues 170,600,000 261,500,000 661,500,000 767,100,000
Breast Health | International        
Disaggregation of Revenue [Line Items]        
Revenues 53,400,000 63,900,000 201,300,000 204,500,000
Breast Health | Breast Imaging        
Disaggregation of Revenue [Line Items]        
Revenues 193,200,000 270,000,000.0 718,200,000 805,600,000
Breast Health | Breast Imaging | United States        
Disaggregation of Revenue [Line Items]        
Revenues 145,600,000 214,600,000 541,100,000 627,300,000
Breast Health | Breast Imaging | International        
Disaggregation of Revenue [Line Items]        
Revenues 47,600,000 55,400,000 177,100,000 178,300,000
Breast Health | Interventional Breast Solutions        
Disaggregation of Revenue [Line Items]        
Revenues 30,800,000 55,400,000 144,600,000 166,000,000.0
Breast Health | Interventional Breast Solutions | United States        
Disaggregation of Revenue [Line Items]        
Revenues 25,000,000.0 46,900,000 120,400,000 139,800,000
Breast Health | Interventional Breast Solutions | International        
Disaggregation of Revenue [Line Items]        
Revenues 5,800,000 8,500,000 24,200,000 26,200,000
GYN Surgical        
Disaggregation of Revenue [Line Items]        
Revenues 51,500,000 112,200,000 275,900,000 322,800,000
GYN Surgical | United States        
Disaggregation of Revenue [Line Items]        
Revenues 42,100,000 92,800,000 227,600,000 268,000,000.0
GYN Surgical | International        
Disaggregation of Revenue [Line Items]        
Revenues 9,400,000 19,400,000 48,300,000 54,800,000
Medical Aesthetics        
Disaggregation of Revenue [Line Items]        
Revenues 0 85,000,000.0 65,300,000 238,600,000
Medical Aesthetics | United States        
Disaggregation of Revenue [Line Items]        
Revenues 0 41,600,000 30,900,000 116,500,000
Medical Aesthetics | International        
Disaggregation of Revenue [Line Items]        
Revenues 0 43,400,000 34,400,000 122,100,000
Skeletal Health        
Disaggregation of Revenue [Line Items]        
Revenues 15,200,000 24,400,000 62,300,000 69,800,000
Skeletal Health | United States        
Disaggregation of Revenue [Line Items]        
Revenues 9,000,000.0 15,400,000 39,400,000 42,600,000
Skeletal Health | International        
Disaggregation of Revenue [Line Items]        
Revenues $ 6,200,000 $ 9,000,000.0 $ 22,900,000 $ 27,200,000